CaliPharms Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2013	FY 2012	FY 2012	FY 2011	FY 2010	2009 - 2005
Period Ending	Mar '26 Mar 3, 2026	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	2009 - 2005
Market Capitalization	0	8	-	-	-	-	Upgrade
Enterprise Value	-	11	-	-	-	-	Upgrade
Last Close Price	0.00	0.00	-	-	-	-	Upgrade
PB Ratio	0.00	-3.39	-	-	-	-	Upgrade
Debt / Equity Ratio	-0.02	-0.28	-0.25	-0.70	-0.34	-0.34	Upgrade
Net Debt / Equity Ratio	-0.02	-0.28	-0.25	-0.70	-0.34	-0.34	Upgrade
Net Debt / EBITDA Ratio	-	-	-	-	-	-5.58	Upgrade
Net Debt / FCF Ratio	-0.28	-13.33	-569.93	-14.72	-35.27	-7.64	Upgrade
Quick Ratio	0.00	-	-	-	0	-	Upgrade
Current Ratio	0.00	-	-	-	0	0	Upgrade
Return on Assets (ROA)	-	-	-	-11.79%	-43.30%	-33.05%	Upgrade
Return on Capital Employed (ROCE)	8.80%	8.80%	33.10%	15.30%	8.60%	6.30%	Upgrade
Earnings Yield	-45485.85%	-2.63%	-	-	-	-	Upgrade
FCF Yield	-	-0.61%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-31942.59%	-285.84%	-150.09%	-32.66%	-94.34%	-465.65%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.